Keywords: adria, file, supplemental, nda, montedison/erbamont, us-based, drugmaker

ADRIA TO FILE SUPPLEMENTAL NDA

Article | 25 January 1993

- Montedison/Erbamont's Adria, a US-based drugmaker, is compiling an efficacy supplement for Adriamycin (doxorubicin) in the treatment of islet cell ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in